Silverback Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.1M | 101k | 11.00 |
| 2024-09-30 | $558k | 37k | 15.00 |
| 2024-06-30 | $225k | 26k | 8.51 |
| 2024-03-31 | $996k | 98k | 10.22 |
| 2023-12-31 | $29k | 5.2k | 5.48 |
| 2023-09-30 | $6.7k | 1.8k | 3.78 |
| 2023-03-31 | $348k | 53k | 6.51 |
| 2022-12-31 | $811k | 95k | 8.53 |
| 2022-09-30 | $2.0k | 418 | 4.78 |
| 2021-12-31 | $48k | 7.3k | 6.62 |
| 2021-03-31 | $37k | 841 | 44.00 |
| 2020-12-31 | $699k | 15k | 46.34 |